ZimVie (NASDAQ:ZIMV) Issues FY 2025 Earnings Guidance

ZimVie (NASDAQ:ZIMV) updated its FY 2025 earnings guidance on Wednesday. The company provided EPS guidance of 0.800-0.950 for the period, compared to the consensus EPS estimate of 0.750. The company issued revenue guidance of $445.0 million-$460.0 million, compared to the consensus revenue estimate of $458.0 million.

ZimVie Price Performance

NASDAQ:ZIMV traded down $0.09 during mid-day trading on Wednesday, hitting $13.10. The company’s stock had a trading volume of 185,894 shares, compared to its average volume of 249,283. The company has a market capitalization of $361.55 million, a price-to-earnings ratio of -1.00 and a beta of 2.10. The company has a current ratio of 1.94, a quick ratio of 1.38 and a debt-to-equity ratio of 0.57. ZimVie has a fifty-two week low of $12.70 and a fifty-two week high of $22.40. The stock has a fifty day moving average of $13.77 and a 200-day moving average of $14.81.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.